Enfuego Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1M

  • Investors
  • 6

Enfuego Therapeutics General Information

Description

Operator of a biotech company intended to treat lung, pancreatic, and colon cancers. The company is developing RNA interference-based and antisense oligonucleotide therapeutics, enabling healthcare providers to tackle some of the most challenging targets in cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 37 Linda Lee Circle
  • Pittsboro, NC 27312
  • United States
+1 (615)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 37 Linda Lee Circle
  • Pittsboro, NC 27312
  • United States
+1 (615)

Enfuego Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enfuego Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 28-Oct-2025 $1M Completed Generating Revenue
5. Grant Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Grant 05-Jul-2023 Completed Generating Revenue
2. Accelerator/Incubator 16-Mar-2020 $30K $30K Completed Generating Revenue
1. Grant 01-Jan-2020 $325K Completed Generating Revenue
To view Enfuego Therapeutics’s complete valuation and funding history, request access »

Enfuego Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enfuego Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fox Ventures Corporate Venture Capital
National Institutes of Health Government
University of North Carolina at Chapel Hill University Minority
National Cancer Institute Government
North Carolina Biotechnology Center Not-For-Profit Venture Capital
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Enfuego Therapeutics FAQs

  • When was Enfuego Therapeutics founded?

    Enfuego Therapeutics was founded in 2019.

  • Where is Enfuego Therapeutics headquartered?

    Enfuego Therapeutics is headquartered in Pittsboro, NC.

  • What is the size of Enfuego Therapeutics?

    Enfuego Therapeutics has 2 total employees.

  • What industry is Enfuego Therapeutics in?

    Enfuego Therapeutics’s primary industry is Drug Discovery.

  • Is Enfuego Therapeutics a private or public company?

    Enfuego Therapeutics is a Private company.

  • What is Enfuego Therapeutics’s current revenue?

    The current revenue for Enfuego Therapeutics is .

  • How much funding has Enfuego Therapeutics raised over time?

    Enfuego Therapeutics has raised $1.03M.

  • Who are Enfuego Therapeutics’s investors?

    Fox Ventures, National Institutes of Health, University of North Carolina at Chapel Hill, National Cancer Institute, and North Carolina Biotechnology Center are 5 of 6 investors who have invested in Enfuego Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process